DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Business Affairs Homepage

Why costs rise when physicians consolidate In one study, physician prices increased 14 percent after acquisitions

Will U.S. healthcare innovate or stagnate? Insights from Dr. John Halamka, CIO at Beth Israel Deaconess Medical Center

Wendy Siminski AdvaMed welcomes senior vice president for conferences and events

Three ways good ethics prevent radiologists from breaking the law Why better insight can help imaging professionals avoid unethical behavior

Retail holds key to understanding digital expectations for healthcare Bringing simple and reliable digital interactions to the patient experience

CIVCO Radiotherapy and Adaptiiv ink distribution deal Partnership will increase access to software that personalizes radiotherapy

BWXT to acquire Sotera Health’s Nordion medical isotope business $150M in capital expenditures expected this year

Four ways to attract prospective patients online Helping care seekers get from Google to your facility

With NVIDIA, Canon brings deep learning to its VNA Combining Abierto VNA data with DGX analytics

Physicians should be granted immunity to malpractice lawsuits, says study Recorded a 13 percent decline in adverse events over four years

RefleXion Medical's biology-guided
radiotherapy system

RefleXion raises $100 million for world’s first biology-guided radiotherapy system

by John R. Fischer , Staff Reporter
RefleXion Medical has raised more than $100 million in a Series C round of funding for the development of the first and only biology-guided radiotherapy system (BgRT) for targeted cancer treatment.

The system is designed to irradiate multiple tumors in one session, a feature that RefleXion estimates will benefit many of the 600,000 U.S. patients diagnosed with metastatic cancer each year as well as increase access to care in underserved areas that lack trained technicians and qualified staff.

Story Continues Below Advertisement

The (#1 Resource) for Medical Imaging and Peripherals. Call 1-949-273-8000

As a Master Distributor for major brands Barco, Philips, and Sony, we offer custom imaging solutions. With our renowned OEM Solutions and Service/Repair Center, Ampronix is a one-stop shop for HD Medical LCD Displays--Printers--Recorders--4K Cameras



"Conventional radiotherapy systems are primarily focused on treating individual, solid-tumor cancers,” RefleXion Medical CTO and co-founder Sam Mazin told HCB News. “RefleXion's technology will be able to treat that disease while also expanding the addressable patient population by treating metastatic disease, which involves multiple tumors throughout the body.”

The World Health Organization predicts that more than 13 million global cancer deaths will occur in 2030, a number which the BgRT system is predicted to help reduce, partially by simplifying and automating the radiotherapy treatment process.

The procedure will start out with a PET imaging agent administered into a patient to identify tumors, sending off signals to RefleXion’s technology so that it may direct therapeutic X-rays to one or more of these malignancies in real time.

This will enable the BgRT system to deliver higher doses of radiation than conventional systems and spare a higher amount of surrounding healthy tissue.

In addition, it will also be able to automatically compensate for tumor motion while precisely targeting the disease, a feature that according to Todd Powell, president and CEO of RefleXion, could lead to the annual diagnosis of 750,000 U.S. patients with early stage diseases.

"The funds raised will set the stage for commercialization of our unique system. That includes manufacturing, facilities and staffing in areas of marketing, sales and service" he told HCB News.

Funding for this round was led by the Rise Fund, the global impact investment fund managed by TPG Growth, marking its first investment in health care technology.

Contributions were also made by T. Rowe Price Associates Inc.; China-focused health care investment firm GT Healthcare Capital Partners; Sofinnova Partners; KCK Group; Venrock; Pfizer Venture Investments; and Johnson & Johnson Innovation – JJDC Inc.

RefleXion Medical expects to be treating U.S. patients by mid-2019.

Back to HCB News
  Pages: 1

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED